Corporate News 03-Nov-22
Marksans Pharma to discuss results
On 14 November 2022
Marksans Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2022.
Previous News
Marksans Pharma consolidated net profit rises 31.37% in the December 2022 quarter
( Results - Announcements 13-Feb-23 14:08 )
Marksans Pharma rises after subsidiary receives EIR from US FDA
( Hot Pursuit - 03-Nov-23 13:14 )
Marksans Pharma to table results
( Corporate News - 31-Jul-24 14:13 )
Marksans Pharma Ltd leads gainers in 'A' group
( Hot Pursuit - 05-Jul-22 12:00 )
Marksans Pharma to consider buyback
( Corporate News - 05-Jul-22 09:52 )
Marksans arm receives UK MHRA marketing authorisation for Cyanocobalamin 50mg film coated tablet
( Corporate News - 06-Nov-23 18:30 )
Marksans Pharma receives upgrade in credit ratings
( Corporate News - 30-Jun-21 14:00 )
Marksans Pharma jumps after subsidiary receives market authorization for diarrhoea drug
( Hot Pursuit - 10-Dec-21 09:17 )
Marksans Pharma arm receives UK MHRA approval for four products
( Corporate News - 02-Jul-24 13:41 )
Marksans Pharma standalone net profit rises 17.30% in the September 2021 quarter
( Results - Announcements 10-Nov-21 11:21 )
Marksans Pharma standalone net profit declines 20.73% in the December 2017 quarter
( Results - Announcements 12-Feb-18 17:07 )
Other Stories
Board of NRB Bearings recommends interim dividend
05-Oct-24 09:27
Refex Industries to hold EGM
05-Oct-24 09:26
Allcargo Terminals to hold EGM
05-Oct-24 09:26
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Back
Top